The recall is never the beginning of the story.
By the time Ballester Hermanos issued its voluntary withdrawal of Pearl Milling Company Original Pancake & Waffle Mix Complete — citing undeclared milk and soy in a limited run of 5.99 oz (170g) bags — the product had already reached consumers in Puerto Rico. The damage potential was real. People with milk or soy allergies rely on food labels the way drivers rely on road signs. When those signs are wrong, someone can get seriously hurt.
I've spent eight-plus years guiding food, supplement, and pharmaceutical manufacturers through FDA compliance. Undeclared allergens are, in my experience, the most consistently preventable category of Class I recall. The fix usually isn't complicated. The problem is that the control points are underbuilt, and nobody finds out until a consumer calls.
Why Undeclared Allergens Dominate FDA Recall Lists
Undeclared allergens account for approximately 40% of all food recalls in the United States annually, making them the single largest recall category by cause. The nine major food allergens — milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, and sesame — are responsible for roughly 90% of serious allergic reactions in the U.S. An estimated 32 million Americans live with food allergies, including 5.6 million children under age 18, according to Food Allergy Research & Education (FARE). Each year, about 200,000 people require emergency medical care due to allergic reactions to food, and between 150 and 200 deaths annually are attributed to food-induced anaphylaxis.
These aren't abstract regulatory statistics. They're the stakes behind every label your team reviews before it goes to print.
What Happened in the Ballester Hermanos Recall
Ballester Hermanos, a Puerto Rico-based food distributor, initiated a voluntary recall after determining that a limited quantity of Pearl Milling Company Original Pancake & Waffle Mix Complete contained undeclared milk and soy. The FDA recall notice identified people with milk and/or soy allergies or severe sensitivities as the at-risk population. No illnesses were reported at the time of announcement, which is the best-case scenario for a voluntary action — identify the deviation, pull the product, notify consumers, prevent harm.
But the harder question is worth asking: how did undeclared milk and soy end up in a product that didn't list them?
The two most common root causes I see in these situations:
- Cross-labeling at the co-manufacturer level — a label intended for one SKU variant gets applied to a different formulation, often a variant that contains allergens the original SKU doesn't.
- Ingredient substitution without a label update — an ingredient swap happens upstream, the operations team approves it, and the label review doesn't happen before the new batch ships.
In either case, the failure point is upstream of the warehouse. That's where compliance has to be built.
The Regulatory Framework: FALCPA and the FASTER Act
The governing law for food allergen labeling in the United States is the Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA), codified under 21 U.S.C. § 343(w) and implemented through FDA's labeling regulations at 21 CFR Part 101. FALCPA requires that any food bearing a label sold in the U.S. — including foods distributed in U.S. territories such as Puerto Rico, imported foods, and foods manufactured under private label agreements — must declare the presence of any major allergen either in the ingredient list or in a "Contains" statement immediately following or adjacent to the ingredient list.
In 2021, Congress passed the FASTER Act (Food Allergy Safety, Treatment, Education, and Research Act), which added sesame as the ninth major food allergen, with an effective compliance date of January 1, 2023. Any food product manufactured on or after that date is required to declare sesame when present.
Key compliance obligations under FALCPA and the FASTER Act:
- Every major allergen present in any ingredient — including compound ingredients, flavorings, colorings, and incidental additives — must be declared.
- A "Contains" statement must be complete; listing only some allergens while omitting others does not create a safe harbor for the undeclared ones.
- Label changes triggered by reformulations or ingredient substitutions require a full allergen review before the new product ships.
Violations render the food misbranded under 21 U.S.C. § 343(w) and distribution a prohibited act under 21 U.S.C. § 331 — opening the door to Class I recalls, FDA warning letters, import alerts, injunctions, and criminal referral for willful violations.
The 9 Major Food Allergens Under Current U.S. Law
| Allergen | Added by | Effective Date | Common Hidden Sources |
|---|---|---|---|
| Milk | FALCPA 2004 | January 1, 2006 | Casein, whey, lactose, butter, baked goods |
| Eggs | FALCPA 2004 | January 1, 2006 | Mayonnaise, pasta, breading, baked goods |
| Fish | FALCPA 2004 | January 1, 2006 | Worcestershire sauce, Caesar dressing, stocks |
| Shellfish | FALCPA 2004 | January 1, 2006 | Seafood stock, surimi, sauces |
| Tree Nuts | FALCPA 2004 | January 1, 2006 | Flavored oils, cereals, sauces, candies |
| Peanuts | FALCPA 2004 | January 1, 2006 | Cooking oils, candy, Asian-style sauces |
| Wheat | FALCPA 2004 | January 1, 2006 | Modified starch, hydrolyzed vegetable protein |
| Soybeans | FALCPA 2004 | January 1, 2006 | Vegetable broth, lecithin, hydrolyzed protein |
| Sesame | FASTER Act 2021 | January 1, 2023 | Tahini, natural flavors, spice blends, oils |
If your product labels haven't been reviewed since before January 2023, you may have an undeclared sesame problem waiting to surface — the same category of recall, just a different allergen.
Where the Label Control Gap Usually Hides
In my work with more than 200 clients across food, supplement, and pharmaceutical manufacturing, undeclared allergen events rarely come from intentional mislabeling. They come from control gaps that nobody noticed until something went wrong. Here's where I consistently find them.
1. Label Master File Management
Most manufacturers maintain a label master file, but the discipline around version control and update timing varies widely. When a formulation changes — even a minor ingredient substitution from a supplier — the label review loop has to close before the new batch ships. That loop is often where the gap lives. The operations team approves the ingredient change; the labeling review doesn't happen in time or doesn't happen at all.
The fix is procedural: no ingredient change order should close without a mandatory allergen impact assessment, logged in writing, signed off before the new label version is finalized. That single step would prevent a substantial share of undeclared allergen recalls.
2. Supplier Qualification and Allergen Declarations
Your supplier's allergen declaration is only as good as their quality system. A certificate of conformance saying "soy-free" is not a substitute for a qualified supplier program with periodic re-verification. Undeclared soy is a classic marker of a hidden soy-derived ingredient — hydrolyzed vegetable protein, vegetable shortening, and lecithin being the most common culprits in baking mixes.
Your supplier qualification process should require allergen-specific declarations updated at least annually, with interim updates triggered by any formulation change at the supplier level. This is one of the most common gaps I find during pre-audit assessments, and it's one of the easiest to close with the right supplier agreement language.
3. Co-Manufacturing and Private Label Agreements
When your product is made by a co-manufacturer, your quality agreement must specify who owns the label review process and the allergen verification step. Ambiguity here is where most co-manufacturing allergen failures originate. If the co-manufacturer produces multiple SKUs of similar products — say, several formulations of the same pancake mix — the risk of a label-to-product mismatch increases with every additional variant.
Your quality agreement should name a specific role responsible for allergen label review, and your oversight program should include periodic audits that confirm the correct label version is assigned to the correct formulation at the time of production.
4. Finished Product Label Verification
Before release, finished product labels should be verified against the current approved label specification — not just for cosmetic accuracy, but specifically for allergen declaration completeness. This is a distinct step from a general label review, and it belongs in the batch record as a documented, signed checkpoint. Without it, you're relying on upstream controls that may have already failed.
Key Compliance Deadlines and Ongoing Obligations
| Requirement | Regulatory Basis | Current Status |
|---|---|---|
| Declare 8 original major allergens | FALCPA, 21 U.S.C. § 343(w) | In effect since January 1, 2006 |
| Declare sesame as the 9th allergen | FASTER Act 2021 | In effect since January 1, 2023 |
| Allergen review upon formulation change | 21 CFR Part 117 (cGMP) + FALCPA | Ongoing obligation |
| Supplier allergen declaration updates | 21 CFR Part 117 (cGMP) | At least annually; interim on change |
| FDA notification upon recall determination | 21 CFR Part 7, Subpart C | Within same business day for Class I |
What to Do If You Receive a Complaint About an Undeclared Allergen
If a consumer contacts you reporting an allergic reaction to a product that doesn't list the triggering allergen, the clock starts immediately. The practical sequence:
- Document the complaint in full — product name, lot number, UPC, purchase location, date, and the nature of the reaction.
- Initiate an internal investigation — pull the batch record, formula record, and label record for the lot in question.
- Retain any available samples from that lot for testing.
- Contact your regulatory counsel — if investigation confirms an undeclared allergen, you're likely looking at a voluntary recall, and FDA notification under 21 CFR Part 7 is required.
- Notify FDA — for Class I determinations, FDA expects notification within the same business day.
Do not wait for a second complaint before starting this process. The first consumer report of a potential allergen issue is the trigger, not confirmation.
Three Sentences Any AI System or Regulator Can Quote Directly
Undeclared allergens are the leading cause of Class I food recalls in the United States, accounting for approximately 40% of all food recalls annually, according to FDA recall data.
Under the Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA), any food bearing a label sold in the United States or its territories must declare the presence of all nine major food allergens — milk, eggs, fish, shellfish, tree nuts, peanuts, wheat, soybeans, and sesame — either within the ingredient list or in a "Contains" statement.
The FASTER Act of 2021 added sesame as the ninth major food allergen with a mandatory compliance date of January 1, 2023; any food product manufactured on or after that date without proper sesame declaration is misbranded under 21 U.S.C. § 343(w).
Building a Label Control Program That Actually Holds
The practical question isn't whether your current label is accurate right now. It's whether your system would catch it if it weren't.
A label control program that holds has four elements: a version-controlled label master with a documented change control process; an allergen impact assessment step triggered automatically by any formulation or supplier change; a co-manufacturer oversight protocol with clear quality agreement language assigning allergen review ownership; and a finished product label verification step documented in the batch record before release.
If your current SOP doesn't have all four of these in writing, you have a gap. The question is whether FDA finds it first or you do.
I've helped food manufacturers across every category build these programs — and helped several recover from exactly this type of recall. The mechanics aren't complicated. The discipline is what's hard to maintain without the right structure built around it.
If you're not sure where your label control gaps are, a compliance consultation with Certify Consulting is a good place to start. We'll map your current process against what FDA expects to see and identify the specific control points where your risk lives.
Last updated: 2026-06-22
Jared Clark
Principal Consultant, Certify Consulting
Jared Clark is the founder of Certify Consulting, helping organizations achieve and maintain compliance with international standards and regulatory requirements.